From gene to therapy in spinal and bulbar muscular atrophy: Are we there yet?
Abnormal polyglutamine expansions in the androgen receptor (AR) cause a muscular condition, known as Kennedy's disease or spinal and bulbar muscular atrophy (SBMA). The disease is transmitted in an X-linked fashion and is clinically characterized by weakness, atrophy and fasciculations of the l...
المؤلفون الرئيسيون: | Pennuto, M, Rinaldi, C |
---|---|
التنسيق: | Journal article |
اللغة: | English |
منشور في: |
Elsevier
2017
|
مواد مشابهة
-
Editorial Comment to Castration‐resistant prostate cancer diagnosed during leuprorelin treatment for spinal and bulbar muscular atrophy
حسب: Maria Pennuto, وآخرون
منشور في: (2022-07-01) -
The role of ubiquitination in spinal and bulbar muscular atrophy
حسب: Medha Sengupta, وآخرون
منشور في: (2022-10-01) -
Gene therapy with AR isoform 2 rescues spinal and bulbar muscular atrophy phenotype by modulating AR transcriptional activity
حسب: Lim, WF, وآخرون
منشور في: (2021) -
Current Status of Treatment of Spinal and Bulbar Muscular Atrophy
حسب: Fumiaki Tanaka, وآخرون
منشور في: (2012-01-01) -
Clinical Phenotyping and Biomarkers in Spinal and Bulbar Muscular Atrophy
حسب: Elina Millere, وآخرون
منشور في: (2021-01-01)